When CAR T cells become the disease
Open Access
- 12 March 2026
- journal article
- Published by American Society of Hematology in Blood
- Vol. 147 (11) , 1139-1141
Abstract
In this issue of Blood, Hosoya et al1 report a case of premalignant chimeric antigen receptor (CAR) T cells coexpressing the gut-homing integrin receptor αKeywords
This publication has 10 references indexed in Scilit:
- Long-term follow-up of gastrointestinal CAR T-cell lymphoma: homing, clonal expansion, and response to cyclosporineBlood, 2026
- Is immune effector cell-associated enterocolitis a CAR T-cell lymphoproliferative disorder?Blood Cancer Journal, 2025
- Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibodyNature Medicine, 2025
- CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory MyelomaNew England Journal of Medicine, 2025
- CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53New England Journal of Medicine, 2025
- Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myelomaBlood Cancer Journal, 2024
- Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell TherapyNew England Journal of Medicine, 2024
- Endoscopic and histopathological hints on infections in patients of common variable immunodeficiency disorder with gastrointestinal symptomsBMC Gastroenterology, 2023
- Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple MyelomaNew England Journal of Medicine, 2023
- Indolent T-cell lymphoproliferative disease of the gastrointestinal tractBlood, 2013